SAN FRANCISCO--(BUSINESS WIRE)--Blockchain and healthcare technology company, Opu Labs, has selected California-based growth capital marketplace, Manhattan Street Capital (MSC), to onboard and accredit U.S. purchasers during Opu Lab’s Initial Coin Offering (ICO) – ahead of its token pre-sale on June 26, 2018.
Opu Labs' mission is to improve how the global skincare industry exchanges data, information, and rewards in a way that benefits patients, dermatologists, treatment centers, brand specialists, and product manufacturers. To make that happen, the company is building a suite of AI and blockchain-based technology platforms, – starting with a mobile skincare app – and a token-based ecosystem that will reward its users.
Opu Labs' ICO is being conducted in compliance with U.S. securities law Regulation D Rule 506(c) and is available worldwide, allowing international and accredited U.S.-based purchasers to participate in its token sales – subject to compliance with those regulations.
In order to ensure a fully compliant accreditation process, Opu Labs was keen to engage an experienced financial services firm which could efficiently support potential U.S. purchasers in a process separate from its global ICO site.
Marc Bookman, Opu Labs’s CEO said: “We want to make sure compliance with our Rule 506(c) offering to accredited investors in the U.S. is watertight. Given Manhattan Street Capital’s expertise, it is clear we are in great hands.”
Rod Turner, MSC’s Chairman & CEO, added: “Opu Labs will be one of the major healthcare ICOs for 2018 and we are delighted to be a part of the process. The company’s business model is very well thought through and leverages the potential of the blockchain. We are excited to team up with Opu Labs and to support accredited U.S. purchasers’ participation in this token offering.”
Manhattan Street Capital is the premier online fundraising platform; helping companies raise IPO capital, and assisting ICOs to become legitimate securities offerings – using the correct Regulation A+, Regulation D, and Regulation S processes.
Opu Labs’ pre-sale opens June 26, 2018 and its public sale begins July 17, 2018. Opu Labs’ whitelist continues to grow and more than 60,000 people have created an account and a personal Opu Wallet at Opu.ai.
For a more detailed description of the token sale, visit the offering page
Read our Whitepaper: http://ico.opu.ai/whitepaper
Join our Telegram group: https://t.me/opulabs
Catch us on Twitter: https://twitter.com/opulabs
Follow us on Facebook: https://www.facebook.com/OpuLabs/
Check us out on Instagram: https://www.instagram.com/opulabs/
Connect with us on Reddit; https://www.reddit.com/r/opulabs/
Read what we’re saying on Medium: https://medium.com/opu-labs
For inquiries, contact: email@example.com
AVAILABLE TO ACCREDITED INVESTORS ONLY AS DEFINED UNDER RULE 501 OF REGULATION D OF THE SECURITIES ACT OF 1933 (the “ACT”.) OFFERING IS MADE PURSUANT TO THE EXEMPTION UNDER RULE 506(c) OF THE ACT. THE INVESTMENT DESCRIBED IN THIS DOCUMENT HAS NOT BEEN REVIEWED, APPROVED, ENDORSED OR RECOMMENDED BY MANHATTAN STREET CAPITAL OR ANY OF ITS AFFILIATES OR REPRESENTATIVES (COLLECTIVELY, “MSC”). MSC GIVES NO WARRANTY OR RECOMMENDATION, EXPRESS OR IMPLIED, AS TO SUCH INVESTMENT, INCLUDING (WITHOUT LIMITATION) THE SUITABILITY, RISKS OR POTENTIAL BENEFITS THEREOF. OPU LABS, LTD. IS IN NO WAY AFFILIATED WITH MSC. EACH INVESTOR WHO ELECTS TO INVEST IN OPU LABS, LTD. DOES SO ENTIRELY AT SUCH INVESTOR’S OWN RISK, AND BY MAKING SUCH INVESTMENT, SUCH INVESTOR ACKNOWLEDGES AND AGREES THAT MSC SHALL HAVE NO LIABILITY WHATSOEVER, AND SUCH INVESTOR WAIVES ANY AND ALL RIGHTS AND CLAIM AGAINST MSC, FOR LOSSES, DAMAGES OR OTHER CLAIMS THAT MAY ARISE FROM SUCH INVESTMENT (INCLUDING, WITHOUT LIMITATION, BASED ON ANY ALLEGED MISREPRESENTATION, NEGLIGENCE OR WILLFUL MISCONDUCT OF OPU LABS, LTD., OR ANY AGENT OR REPRESENTATIVE THEREOF).
THE OFFER AND SALE OF THE SECURITIES DESCRIBED HEREIN HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.